Filtros de búsqueda

Lista de obras de

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL.

artículo científico publicado en 2009

A case of primary esophageal mucosa-associated lymphoid tissue lymphoma with a numerical abnormality of 18q21 detected by fluorescence in situ hybridization

article

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study ⬇️

artículo científico publicado el 29 de diciembre de 2010

A randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma

artículo científico publicado en 2016

Aclarubicin plus behenoyl cytarabine and prednisolone for previously treated acute myeloid leukemia patients.

artículo científico publicado en 2006

Acute lymphoblastic leukemia

artículo científico publicado en 2009

Acute lymphoblastic leukemia and chronic lymphocytic leukemia in adults

artículo científico publicado el 1 de febrero de 2012

Administration Schedule of Daunorubicin for Elderly Patients with Acute Myelogenous Leukemia: A Single-institute Experience ⬇️

artículo científico publicado el 16 de marzo de 2011

Appropriate use of granulocyte colony-stimulating factor in the management of hematologic malignancies

artículo científico publicado en 2014

Appropriate use of granulocyte-colony stimulating factor in treating hematologic malignancies

artículo científico publicado en 2015

CD2+ tetraploid acute promyelocytic leukemia variant with double (15;17) translocations

artículo científico publicado en 2005

Carcinoembryonic antigen-producing multiple myeloma detected by a transcription-reverse transcription concerted reaction system

artículo científico publicado en 2007

Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates

artículo científico publicado en 2006

Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study

artículo científico publicado en 2008

Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group

scientific article published on 01 June 2006

Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study

scientific article published on 24 September 2018

Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2016

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia

artículo científico publicado en 2004

Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211

artículo científico publicado en 2012

Correction to: JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN).

artículo científico publicado en 2017

Current chemotherapy of adult acute lymphoblastic leukemia

artículo científico publicado en 2010

Current management of adult acute lymphoblastic leukemia/lymphoma

artículo científico publicado el 1 de octubre de 2011

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.

artículo científico publicado en 2017

Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia ⬇️

artículo científico publicado el 16 de diciembre de 2011

Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide

artículo científico publicado en 2004

Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study

artículo científico publicado en 2012

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

artículo científico publicado en 2018

Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system

scientific article published on 14 February 2019

Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF).

artículo científico publicado en 2007

Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan ⬇️

artículo científico publicado el 28 de junio de 2013

Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review

artículo científico publicado en 2017

Evaluation of clinical performance of the major BCR-ABL mRNA detection kit which enables conversion to international standard scale using the reference material calibrator

artículo científico publicado en 2014

Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia

artículo científico publicado en 2009

Hematologic malignancies/ pediatric malignancies-chronic myeloid leukemia

artículo científico publicado el 1 de mayo de 2011

Hematologic malignancies/pediatric malignancies

artículo científico publicado el 1 de mayo de 2012

Hematologic malignancies/pediatric malignancy

artículo científico publicado en 2013

Hematological malignancies

artículo científico publicado en 2007

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

artículo científico publicado en 2005

Human herpesvirus 8-negative primary effusion lymphoma-like lymphoma with t(8;14)(q24;q32)

artículo científico publicado en 2015

Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan

artículo científico publicado en 2010

Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature

artículo científico publicado en 2020

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study ⬇️

artículo científico publicado el 10 de septiembre de 2010

Intensified daunorubicin in induction therapy and autologous peripheral blood stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute myeloid leukemia

artículo científico publicado en 2002

Intensifying daunorubicin in induction for patients with core binding factor leukemia

artículo científico publicado en 2006

Intravascular large B cell lymphoma with migratory local high density shadow by chest CT and diagnosed by transbronchial lung biopsy

artículo científico publicado en 2002

JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN).

artículo científico publicado en 2017

Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy

artículo científico publicado en 2008

Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis

artículo científico publicado en 2011

Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 1. Treatment for adult acute myeloid leukemia

artículo científico publicado en 2013

Long-term follow-up high-dose chemotherapy (drug-only program) followed by autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas

artículo científico publicado en 2005

Long-term follow-up of autologous stem cell transplantation for patients with aggressive non-Hodgkin lymphoma who had bone marrow involvement at initial diagnosis in the pre-rituximab era

artículo científico publicado en 2007

Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study ⬇️

artículo científico publicado el 16 de abril de 2012

Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "lung injury by bortezomib" joint committee of the Japanese society of hematology and the Japanese society of clin

artículo científico publicado en 2006

Management of acute lymphoblastic leukemia

artículo científico publicado en 2008

Management of chronic myeloid leukemia for Japanese patients in the era of TKIs

artículo científico publicado en 2014

Management of pH-positive acute lymphoblastic leukemia

artículo científico publicado el 1 de abril de 2012

Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia

artículo científico publicado en 2004

Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemia

artículo científico publicado en 2004

Myelodysplastic syndrome with myelofibrosis in which azacitidine therapy was effective and cord blood transplantation was carried out

artículo científico publicado en 2017

New therapeutic strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia

artículo científico publicado en 2006

Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia

artículo científico publicado en 2006

Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation

artículo científico publicado en 2014

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

artículo científico publicado en 2009

Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

artículo científico publicado en 2011

Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).

artículo científico publicado en 2007

Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study

artículo científico publicado en 2011

Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab.

artículo científico publicado en 2009

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

artículo científico publicado en 2009

Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study

artículo científico publicado en 2009

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

scientific article published on 06 February 2019

Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia

artículo científico publicado en 2005

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study

artículo científico publicado en 2017

Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy

scientific article published on 01 August 2007

Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia

artículo científico publicado en 2020

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

artículo científico publicado en 2018

Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy

artículo científico publicado en 2014

Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia

artículo científico publicado en 2017

Progressive outer retinal necrosis in a patient with malignant lymphoma

artículo científico publicado en 2004

Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan

artículo científico publicado en 2019

Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy

artículo científico publicado en 2008

Pseudo-Gaucher cell proliferation associated with myelodysplastic syndrome

artículo científico publicado en 2007

Purification and characterization of C-terminal truncated forms of histone H2A in monocytic THP-1 cells

artículo científico publicado en 2006

Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study ⬇️

artículo científico publicado el 6 de agosto de 2010

Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients ⬇️

artículo científico publicado el 2 de marzo de 2011

Salvage therapy for primary refractory and relapsed adult acute lymphoblastic leukemia

artículo científico publicado el 1 de abril de 2012

Septic intramuscular embolism in a neutropenic patient with myelodysplastic syndrome accompanied by asymptomatic septic pulmonary emboli

artículo científico publicado en 2005

Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report

artículo científico publicado el 1 de octubre de 2003

Successful combination therapy with trastuzumab and Paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer

artículo científico publicado en 2004

Successful immunosuppressive therapy with cyclosporine A for posthepatitis B-cell deficiency with activated cytoplasmic interferon--gamma-positive T-lymphocytes

artículo científico publicado en 2002

Successful induction of complete cytogenetic response with high-dose imatinib mesylate and subsequent allogeneic stem cell transplantation for CML blastic crisis

artículo científico publicado en 2003

Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study

artículo científico publicado en 2018

Th1/Th2 lymphocyte balance in patients with aplastic anemia

artículo científico publicado en 2004

Toxicity and outcome of intensive chemotherapy for acute lymphoblastic leukemia complicated with Turner's syndrome

artículo científico publicado en 2005

Two Cases of Mediastinal Gray Zone Lymphoma ⬇️

artículo científico publicado el 1 de enero de 2010

Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.

artículo científico publicado en 2017

[A novel quantitative JAK2V617F detection kit: prospective clinical performance study comparing MPN patients and healthy subjects]

artículo científico publicado en 2018

[A role of new molecular-target drugs for hematologic malignancies]

scientific article published on 01 May 2015

[Acute lymphoblastic leukemia/ lymphoblastic lymphoma: ALL/LBL]

artículo científico publicado en 2019

[Anti-CD33 monoclonal antibody drug conjugate--Gemtuzumab ozogamicin (GO)]

[Chronic myeloid leukemia]

[Clinical usage and future prospective of guidelines in treatment of hematological malignancies]

artículo científico publicado en 2014

[Current treatment for malignant lymphomas].

artículo científico publicado en 2007

[Gemtuzumab ozogamicin as monotherapy and combination therapy for acute myelogenous leukemia]

artículo científico publicado en 2007

[Hematologic Malignancies/Pediatric Malignancies Acute Leukemia - Current Treatment and Future Perspective]

Scientific article published May 2017

[Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies]

scientific article published on 01 May 2019

[Hematologic Malignancies/Pediatric Malignancies New Therapeutic Strategy for Hematologic Malignancies]

scientific article published on 01 May 2018

[Hematologic Malignancies/Pediatric Malignancies. Roles of Drugs Approved as New Agents and as Additional Indications for Relapse or Refractory Hematologic Malignancies]

[Hematologic malignancies /pediatric malignancies-current status of molecular target therapy for hematologic cancer]

artículo científico publicado en 2010

[Hematologic malignancies/pediatric malignancies]

artículo científico publicado en 2009

[High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute]

artículo científico publicado en 2010

[Imatinib therapy for patients with chronic myelogenous leukemia]

scientific article published on 01 March 2005

[Inhibitors for Notch and gamma-secretase. Biology of T-cell leukemia]

artículo científico publicado en 2009

[Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Cli

scientific article published on 01 December 2006

[Lymphoid malignancies: Progress in diagnosis and treatment. Topics: III. Diagnosis and treatment; 1. Management of acute lymphoblastic leukemia and chronic lymphocytic leukemia]

scientific article published on 01 July 2011

[Malignant lymphomas].

artículo científico publicado en 2009

[Outcomes of primary central nervous system lymphoma patients treated with high-dose methotrexate and rituximab]

scientific article published on 01 January 2019

[Overview]

artículo científico publicado en 2018

[Physiopathology, diagnosis and treatment of chronic myeloproliferative diseases: discussion]

artículo científico publicado en 2007

[Pseudoleukocytosis and pseudothrombocytosis caused by fragmentation of leukemic cells in tumor lysis syndrome]

artículo científico publicado en 2007

[T-cell acute lymphoblastic leukemia]

artículo científico publicado en 2009

[Treatment of acute Leukemia]

artículo científico publicado en 2014

[Treatment of adult patients with acute myeloid leukemia (excluding acute promyelocytic leukemia)]

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda